Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Haas, S 
Titel:
Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme. 
Abstract:
Anticoagulants are recommended for the prevention and treatment of venous thromboembolism (VTE), prevention of stroke in patients with atrial fibrillation (AF) and secondary prevention in patients with acute coronary syndrome (ACS). There is a clinical need for novel anticoagulants offering improvements over current standard of care, such as fixed oral dosing and no need for routine monitoring. Rivaroxaban, an oral, once-daily, direct Factor Xa inhibitor, has recently completed the RECORD phase...    »
 
Zeitschriftentitel:
Eur J Haematol 
Jahr:
2009 
Band / Volume:
82 
Heft / Issue:
Seitenangaben Beitrag:
339-49 
Sprache:
eng 
Print-ISSN:
0902-4441 
TUM Einrichtung:
r experimentelle Onkologie und Therapieforschung